TMDX TransMedics Group, Inc. Stock Quote

TMDX [NASD]

Index	-	P/E	-	EPS (ttm)	-1.20	Insider Own	1.70%	Shs Outstand	27.16M	Perf Week	-9.09%
Market Cap	726.72M	Forward P/E	-	EPS next Y	-0.60	Insider Trans	-69.92%	Shs Float	25.29M	Perf Month	-42.71%
Income	-28.70M	PEG	-	EPS next Q	-0.29	Inst Own	80.60%	Short Float	3.85%	Perf Quarter	36.18%
Sales	25.60M	P/S	28.39	EPS this Y	50.70%	Inst Trans	-2.13%	Short Ratio	1.04	Perf Half Y	99.77%
Book/sh	3.83	P/B	6.79	EPS next Y	43.90%	ROA	-20.10%	Target Price	-	Perf Year	65.77%
Cash/sh	4.50	P/C	5.78	EPS next 5Y	-	ROE	-30.80%	52W Range	11.51 - 49.50	Perf YTD	30.70%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-19.10%	52W High	-47.45%	Beta	-
Dividend %	-	Quick Ratio	11.40	Sales past 5Y	-	Gross Margin	64.90%	52W Low	125.98%	ATR	3.56
Employees	110	Current Ratio	12.40	Sales Q/Q	24.60%	Oper. Margin	-	RSI (14)	30.97	Volatility	6.70% 9.97%
Optionable	Yes	Debt/Eq	0.33	EPS Q/Q	46.40%	Profit Margin	-	Rel Volume	0.69	Prev Close	27.03
Shortable	Yes	LT Debt/Eq	0.33	Earnings	Mar 02 AMC	Payout	-	Avg Volume	937.87K	Price	26.01
Recom	2.00	SMA20	-29.58%	SMA50	-25.75%	SMA200	22.35%	Volume	644,492	Change	-3.77%

Oct-08-20

Downgrade

JP Morgan

Overweight → Neutral

$15

Apr-07-20

Initiated

Oppenheimer

Outperform

$25

May-28-19

Initiated

Morgan Stanley

Equal-Weight

May-28-19

Initiated

JP Morgan

Overweight

May-28-19

Initiated

Cowen

Outperform

May-28-19

Initiated

Canaccord Genuity

Buy

Apr-15-21 05:30AM	TransMedics Group's Charts Are Pointed Lower TheStreet.com -5.29%
Apr-09-21 07:41AM	What Type Of Shareholders Own The Most Number of TransMedics Group, Inc. (NASDAQ:TMDX) Shares? Simply Wall St.
Apr-07-21 08:50AM	TransMedics Stock Is Trading Higher After FDA Adcom Votes In Favor Of Its OCS Heart System Benzinga
Apr-06-21 10:20PM	TransMedics Announces Positive FDA Advisory Committee Vote for OCS Heart System PR Newswire
05:30PM	How Jonah Lupton Expects TransMedics Group Stock To React To FDA Decision Benzinga
07:05AM	TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Heart System PR Newswire
Mar-24-21 04:05PM	TransMedics Appoints Stephanie Lovell to Board of Directors PR Newswire -5.91%
Mar-12-21 06:01AM	Got $2,000? These 3 Unstoppable Stocks Could More Than Double Your Money Motley Fool
Mar-10-21 01:00PM	3 Healthcare Companies Worth a Look Motley Fool
Mar-04-21 12:29AM	US$40.80 - That's What Analysts Think TransMedics Group, Inc. (NASDAQ:TMDX) Is Worth After These Results Simply Wall St. -14.52%
Mar-02-21 05:35PM	TransMedics (TMDX) Reports Q4 Loss, Tops Revenue Estimates Zacks +9.58%
04:38PM	TransMedics Group: Q4 Earnings Insights Benzinga
04:01PM	TransMedics Reports Fourth Quarter and Full Year 2020 Financial Results PR Newswire
02:30PM	TransMedics Group, Inc. to Host Earnings Call ACCESSWIRE
Mar-01-21 04:15PM	TransMedics Announces Scheduling of OCS Heart FDA Advisory Committee Meeting PR Newswire
Feb-16-21 04:05PM	TransMedics to Present at the Cowen 41st Annual Healthcare Conference PR Newswire -6.26%
04:01PM	TransMedics to Report Fourth Quarter and Full Year 2020 Financial Results on March 2, 2021 PR Newswire
Feb-05-21 08:44AM	Did You Miss TransMedics Group's (NASDAQ:TMDX) 31% Share Price Gain? Simply Wall St.
Dec-24-20 08:00AM	TransMedics to Present at the 39th Annual J.P. Morgan Healthcare Conference PR Newswire
Dec-23-20 04:01PM	TransMedics Appoints Merilee Raines to Board of Directors PR Newswire
Dec-07-20 04:06PM	Is TMDX A Good Stock To Buy Now? Insider Monkey
Nov-04-20 08:31PM	TransMedics Group, Inc. (TMDX) Q3 2020 Earnings Call Transcript Motley Fool
06:45PM	TransMedics (TMDX) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:01PM	TransMedics Reports Third Quarter 2020 Financial Results PR Newswire
02:30PM	TransMedics Group, Inc. to Host Earnings Call ACCESSWIRE
Oct-29-20 04:02PM	TransMedics to Participate in Upcoming Virtual Investor Conferences PR Newswire
03:00PM	Austpro Closes Financing ACCESSWIRE
Oct-28-20 12:33PM	Will TransMedics (TMDX) Report Negative Earnings Next Week? What You Should Know Zacks
Oct-21-20 04:01PM	TransMedics to Report Third Quarter 2020 Financial Results on November 4, 2020 PR Newswire
Oct-19-20 06:10PM	Austpro Announces Private Placement ACCESSWIRE
Sep-28-20 04:05PM	TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting GlobeNewswire
Sep-01-20 04:30PM	TransMedics to Present at the 18th Annual Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-05-20 04:01PM	TransMedics Reports Second Quarter 2020 Financial Results GlobeNewswire
Jul-29-20 12:33PM	TransMedics (TMDX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release Zacks
Jul-28-20 04:01PM	TransMedics to Present at the Canaccord 40th Annual Growth Conference GlobeNewswire
01:52PM	Speculative TransMedics Group Looks Ready to Start an Upside Move TheStreet.com
Jul-23-20 08:00AM	TransMedics to Report Second Quarter 2020 Financial Results on August 5, 2020 GlobeNewswire
Jun-04-20 10:11PM	Is TransMedics Group, Inc. (TMDX) Going to Burn These Hedge Funds? Insider Monkey
May-27-20 11:14AM	Why TransMedics Group Is Plunging Today Motley Fool -12.35%
May-26-20 06:50PM	TransMedics Announces Pricing of Public Offering of Common Stock GlobeNewswire
07:14AM	TransMedics Announces Proposed Public Offering of Common Stock GlobeNewswire
07:09AM	TransMedics Announces Positive Top-line Results from U.S. Pivotal OCS Liver PROTECT Trial GlobeNewswire
May-07-20 11:30AM	TransMedics Group, Inc. (TMDX) Q1 2020 Earnings Call Transcript Motley Fool -6.88%
May-06-20 04:05PM	TransMedics Reports First Quarter 2020 Financial Results GlobeNewswire
Apr-29-20 12:34PM	Will TransMedics (TMDX) Report Negative Earnings Next Week? What You Should Know Zacks
Apr-23-20 04:05PM	TransMedics to Report First Quarter 2020 Financial Results on May 6, 2020 GlobeNewswire
Apr-13-20 04:05PM	TransMedics Provides COVID-19 Pandemic Update and Announces Preliminary Financial Results for First Quarter 2020 GlobeNewswire
Mar-17-20 09:20AM	How Many TransMedics Group, Inc. (NASDAQ:TMDX) Shares Did Insiders Buy, In The Last Year? Simply Wall St. +20.76%
07:00AM	TransMedics Announces Temporary Postponement of OCS Heart FDA Advisory Panel Committee Meeting Due to COVID-19 Emergency GlobeNewswire
Mar-02-20 04:05PM	TransMedics Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire
Feb-20-20 04:05PM	TransMedics to Present at the Cowen 40th Annual Health Care Conference GlobeNewswire
Feb-19-20 04:05PM	TransMedics to Report Fourth Quarter and Full Year 2019 Financial Results on March 2, 2020 GlobeNewswire
Jan-17-20 09:39AM	Does TransMedics Group (NASDAQ:TMDX) Have A Healthy Balance Sheet? Simply Wall St.
Dec-22-19 05:10PM	Here is What Hedge Funds Think About TransMedics Group, Inc. (NASDAQ:TMDX) Insider Monkey
Dec-19-19 08:00AM	TransMedics to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-09-19 08:58AM	TransMedics' OCS Technology Sees Success in Heart Transplant Zacks +5.10%
Dec-04-19 08:00AM	TransMedics Organ Care System (OCS) Technology Used in First U.S. Adult Human Heart Transplants From DCD Donors GlobeNewswire
Nov-06-19 07:30AM	TransMedics Reports Third Quarter 2019 Financial Results GlobeNewswire -10.85%
Nov-01-19 02:17PM	Are Investors Undervaluing TransMedics Group, Inc. (NASDAQ:TMDX) By 32%? Simply Wall St. +8.75%
Oct-23-19 04:05PM	TransMedics Announces Change to Time of Third Quarter 2019 Earnings Conference Call on Wednesday, November 6 GlobeNewswire
Oct-16-19 04:05PM	TransMedics to Report Third Quarter 2019 Financial Results on November 6, 2019 GlobeNewswire
Sep-17-19 01:45PM	When Will TransMedics Group, Inc. (NASDAQ:TMDX) Turn A Profit? Simply Wall St.
Aug-26-19 04:05PM	TransMedics to Present at the 17th Annual Morgan Stanley Global Healthcare Conference GlobeNewswire
Aug-21-19 05:35PM	David Abrams Keeps Boosting Camping World, Gains 2 New Holdings in 2nd Quarter GuruFocus.com
Aug-07-19 04:05PM	TransMedics Reports Second Quarter 2019 Financial Results GlobeNewswire
Aug-02-19 08:21AM	What Kind Of Shareholder Appears On The TransMedics Group, Inc.'s (NASDAQ:TMDX) Shareholder Register? Simply Wall St.
Jul-30-19 08:30AM	TransMedics Announces Successful Long Distance Retrieval and Transplantation of Donor Lungs from Hawaii Using Organ Care System (OCS) GlobeNewswire
Jul-25-19 04:05PM	TransMedics to Present at the 39th Annual Canaccord Genuity Global Growth Conference GlobeNewswire
Jul-17-19 04:05PM	TransMedics to Report Second Quarter 2019 Financial Results on August 7, 2019 GlobeNewswire
Jun-30-19 08:11AM	3 IPO Stocks With Plenty of Growth Ahead TipRanks
Jun-11-19 04:05PM	TransMedics Reports First Quarter 2019 Financial Results GlobeNewswire
02:30PM	TransMedics Group, Inc. to Host Earnings Call ACCESSWIRE
Jun-03-19 08:00AM	TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage GlobeNewswire
May-30-19 04:05PM	TransMedics to Report First Quarter 2019 Financial Results on June 11, 2019 GlobeNewswire
May-06-19 04:15PM	TransMedics Announces Closing of its Initial Public Offering and Full Exercise of Underwriters Option to Purchase Additional Shares GlobeNewswire +10.52%
May-01-19 01:25PM	TransMedics Group IPO: What You Need To Know Benzinga

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG, a portable perfusion, ventilation, and monitoring system that maintains the organ at a near-physiologic state allowing physicians to assess and improve the condition of lungs between the donor and recipient sites; OCS Heart, a portable, warm perfusion, and monitoring system designed to keep a donor heart at a human-like, metabolically active state; and OCS Liver, a system that is evaluated in clinical trials for utilized and unutilized donor livers. TransMedics Group, Inc. was founded in 1998 and is headquartered in Andover, Massachusetts.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sullivan John F	VP of Quality & Engineering	Apr 07	Option Exercise	5.00	15,000	74,940	25,828	Apr 09 07:38 PM
Sullivan John F	VP of Quality & Engineering	Apr 07	Sale	36.83	15,000	552,394	10,828	Apr 09 07:38 PM
Carey John F	VP of Operations	Apr 05	Option Exercise	16.14	3,360	54,230	3,360	Apr 07 06:34 PM
Hassanein Waleed H	President & CEO	Apr 05	Option Exercise	0.28	125,000	35,000	403,843	Apr 07 06:35 PM
Carey John F	VP of Operations	Apr 05	Sale	36.87	3,360	123,883	0	Apr 07 06:34 PM
Hassanein Waleed H	President & CEO	Apr 01	Sale	40.63	60,000	2,437,871	278,843	Apr 05 06:17 PM
Gordon Stephen	Chief Financial Officer	Mar 15	Option Exercise	0.67	10,000	6,700	10,000	Mar 16 06:14 PM
Gordon Stephen	Chief Financial Officer	Mar 15	Sale	39.81	10,000	398,100	0	Mar 16 06:14 PM
Carey John F	VP of Operations	Mar 11	Sale	37.50	3,200	120,000	0	Mar 11 09:19 PM
Hassanein Waleed H	President & CEO	Mar 10	Option Exercise	2.21	35,007	77,365	373,850	Mar 11 09:17 PM
Hassanein Waleed H	President & CEO	Mar 10	Sale	33.79	35,007	1,182,963	338,843	Mar 11 09:17 PM
Khayal Tamer I	Chief Commercial Officer	Mar 08	Option Exercise	0.28	20,000	5,600	66,076	Mar 09 05:36 PM
Khayal Tamer I	Chief Commercial Officer	Mar 08	Sale	32.00	20,000	640,000	46,076	Mar 09 05:36 PM
Khayal Tamer I	Chief Commercial Officer	Mar 05	Option Exercise	0.36	20,000	7,200	66,076	Mar 09 05:36 PM
Khayal Tamer I	Chief Commercial Officer	Mar 05	Sale	30.90	20,000	618,099	46,076	Mar 09 05:36 PM
Gordon Stephen	Chief Financial Officer	Feb 16	Option Exercise	0.67	10,000	6,700	10,000	Feb 17 05:43 PM
Gordon Stephen	Chief Financial Officer	Feb 16	Sale	31.33	10,000	313,300	0	Feb 17 05:43 PM
Sullivan John F	VP of Quality & Engineering	Feb 09	Option Exercise	0.28	8,600	2,408	19,428	Feb 11 08:57 AM
ABRAMS CAPITAL MANAGEMENT, L.P	10% Owner	Feb 09	Sale	33.32	786,664	26,208,734	2,624,712	Feb 10 04:53 PM
TOBIN JAMES R	Director	Feb 09	Sale	32.83	10,168	333,786	424,637	Feb 10 06:59 PM
Sullivan John F	VP of Quality & Engineering	Feb 09	Sale	32.81	8,600	282,188	10,828	Feb 11 08:57 AM
Gordon Stephen	Chief Financial Officer	Feb 08	Option Exercise	0.67	1,429	957	1,429	Feb 10 07:00 PM
Gordon Stephen	Chief Financial Officer	Feb 08	Sale	25.01	10,000	250,100	0	Feb 10 07:00 PM
ABRAMS CAPITAL MANAGEMENT, L.P	10% Owner	Feb 08	Sale	26.24	88,483	2,321,705	3,411,376	Feb 10 04:53 PM
Sullivan John F	VP of Quality & Engineering	Jan 19	Option Exercise	0.39	9,617	3,751	20,445	Jan 20 09:00 PM
Sullivan John F	VP of Quality & Engineering	Jan 19	Sale	22.12	9,617	212,728	10,828	Jan 20 09:00 PM
Hassanein Waleed H	President & CEO	Jan 05	Option Exercise	0.39	123,414	48,131	338,843	Jan 14 06:56 PM
Gordon Stephen	Chief Financial Officer	Jan 04	Sale	20.00	1,184	23,680	8,371	Jan 05 06:04 PM
Gordon Stephen	Chief Financial Officer	Dec 31	Sale	20.00	8,816	176,320	9,755	Jan 05 06:04 PM
Sullivan John F	VP of Quality & Engineering	Dec 21	Sale	17.99	1,000	17,990	10,828	Dec 22 04:19 PM
Sullivan John F	VP of Quality & Engineering	Dec 16	Option Exercise	0.39	1,000	390	11,828	Dec 17 05:57 PM
Sullivan John F	VP of Quality & Engineering	Dec 15	Option Exercise	0.39	3,000	1,170	13,828	Dec 17 05:57 PM
Sullivan John F	VP of Quality & Engineering	Dec 15	Sale	16.63	3,000	49,890	10,828	Dec 17 05:57 PM
Provost Miriam	VP of US Regulatory & FDA Rel.	Dec 11	Option Exercise	3.22	4,600	14,812	4,600	Dec 14 04:53 PM
Carey John F	VP of Operations	Sep 01	Option Exercise	0.39	2,000	780	5,200	Sep 03 06:41 PM
Carey John F	VP of Operations	Sep 01	Sale	17.59	2,000	35,180	3,200	Sep 03 06:41 PM
Carey John F	VP of Operations	Aug 03	Option Exercise	2.21	2,000	4,420	5,200	Aug 05 08:08 PM
Carey John F	VP of Operations	Aug 03	Sale	18.61	2,000	37,214	3,200	Aug 05 08:08 PM
Carey John F	VP of Operations	Jul 01	Option Exercise	1.40	2,000	2,793	5,200	Jul 02 07:42 PM
Carey John F	VP of Operations	Jul 01	Sale	17.09	2,000	34,174	3,200	Jul 02 07:42 PM
Carey John F	VP of Operations	Jun 01	Option Exercise	0.39	2,000	780	5,200	Jun 02 06:10 PM
Carey John F	VP of Operations	Jun 01	Sale	13.21	2,000	26,420	3,200	Jun 02 06:10 PM
Carey John F	VP of Operations	May 01	Option Exercise	0.39	2,000	780	5,200	May 04 06:04 PM
Carey John F	VP of Operations	May 01	Sale	17.05	2,000	34,105	3,200	May 04 06:04 PM
Gordon Stephen	Chief Financial Officer	Apr 27	Sale	18.00	9,900	178,200	18,571	Apr 29 04:22 PM
Gordon Stephen	Chief Financial Officer	Apr 22	Sale	18.00	100	1,800	28,471	Apr 24 05:54 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience